SACS and Charlevoix-Saguenay spastic ataxia: As we previously showed in the fibroblasts of the same patient,7 the levels of full-length sacsin were identical with or without MG-132 (Supplementary Fig. 1A), indicating that post-translational degradation is not the mechanism accounting for mutant sacsin reduction in PBMCs of patients with ARSACS.